Vergent Bioscience, Inc. — Form D

Vergent Bioscience, Inc. of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-22. The offering totals $2.0M, of which $1.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Samuel Dean BanksDirectorMINNEAPOLIS, MN
Ryan Dean EgelandDirectorMINNEAPOLIS, MN
Douglas Dean KohrsDirectorMINNEAPOLIS, MN
Raymond Dean WongDirectorMINNEAPOLIS, MN
Jeffrey Dean YureckoExecutive OfficerMINNEAPOLIS, MN
Douglas KohrsDirectorDALLAS, TX
Ryan EgelandDirectorMaple Grove, MN
Bobby T HelmedagDirectorMinneapolis, MN
Jeffrey T YureckoExecutive OfficerMinneapolis, MN
Anita T WatkinsDirectorMinneapolis, MN
John T Santini, Jr.DirectorMinneapolis, MN
John T Santini, Jr.Executive OfficerMinneapolis, MN
Raymond T WongDirectorMinneapolis, MN
Douglas T KohrsDirectorMinneapolis, MN
Jeff JulkowskiDirectorMinneapolis, MN
Raymond WongDirectorHong Kong, K3
Jeffrey YureckoExecutive OfficerMinneapolis, MN
John SantiniDirectorMinneapolis, MN
John SantiniExecutive OfficerMinneapolis, MN
Anita WatkinsDirectorMinneapolis, MN
Samuel Dean BanksDirectorMinneapolis, MN
Anita WilsonDirectorMinneapolis, MN
Samuel BanksDirectorToronto, A6
Margo ShoupDirectorMINNEAPOLIS, MN
Jeffrey JulkowskiDirectorMINNEAPOLIS, MN

Other filings by this issuer (7)

FiledFormOfferingSold
2025-10-20D$32.0M$18.7M
2025-02-18D$5.0M$3.8M
2025-02-18D/A$5.0M$3.8M
2022-10-04D$22.1M$21.5M
2020-09-23D/A$11.9M$11.9M
2019-02-22D/A$9.7M$9.7M
2018-06-01D$8.7M$8.7M

More